CV Sciences Inc (CVSI)

[CannabidiolHead]

For 2016 CANV's inventory levels are sufficient to support their sales so the company doesn't plan to purchase raw inventory from its supply chain arrangements. They will need to find around $1.5 million over the next 12 months in order to support the pharmaceutical business segment, though. At the very end of last year CANV acquired two product candidates after completing the acquisition of CanX, Inc. and it hopes to file an Investigational New Drug application with the FDA in the future.